Hot Growth Stocks To Watch For 2023


Silgan Holdings Inc. (SLGN Quick QuoteSLGN ) recently acquired Gateway Plastics for $485 million, in order to expand its wide range of product offerings in the Dispensing and Specialty Closures business, while providing additional growth scopes for the existing customers.

Gateway Plastics manufactures dispensing closures and integrated dispensing packaging solutions, and sells these to consumer goods product companies, mainly serving the food and beverage markets. The company has a large state-of-the-art manufacturing plant in Mequon, WI, which is expected to generate around $150 million in revenues and adjusted EBITDA of $46 million in 2021.

This growth capacity, along with its consistent focus on meeting customer needs, makes Gateway Plastics a perfect fit for Silgan, which is a leading global supplier of dispensing and specialty closures for consumer goods products.


Silgan projects to realize tax benefits of $90 million from this buyout. Annual synergies of approximately $2 million are expected within 12 months of the acquisition. These synergies would be achieved primarily through its procurement savings. Silgan funded the deal with revolving loan facilities under its senior secured credit facility. The buyout is likely to be slightly accretive to Silgan’s bottom-line performance in the current year, while an additional accretion is expected in the next year.

Last June, Silgan acquired Albea’s dispensing business in a bid to strengthen its position in the dispensing markets. The company expects to realize annual run-rate operational cost synergies of $20 million from this buyout, by the end of 2021. These acquisitions, coupled with investments in several capacity expansion projects for dispensing triggers and pumps, will aid Silgan to tap the significant growth in demand for health and hygiene products.


Silgan’s Dispensing and Specialty Closures segment will gain from the recovery in the beverage, beauty and fragrance markets in the current year. Along with the Albea buyout, new business gains, improved manufacturing efficiencies and higher pension income will drive the segment’s income.

Silgan expects adjusted earnings per share in the range of $3.30 to $3.45 in 2021. The mid-point of the guided range indicates a year-over-year improvement of 10.3%. The company’s continued focus on cost reduction will help counter inflated material costs and labor supply challenges.

Hot Growth Stocks To Watch For 2023: MEDIFAST INC(MED)


Medifast, Inc., through its subsidiaries, engages in the production, distribution, and sale of weight management and disease management products, and other consumable health and diet products in the United States. The company?s product lines include weight and disease management, meal replacement, and vitamins. It also operates weight control centers that offer Medifast programs for weight loss and maintenance, customized patient counseling, and inbody composition analysis. The company markets its products under the Medifast and Essential brand names, including shakes, appetite suppression shakes, women?s health shakes, diabetics shakes, joint health shakes, coronary health shakes, calorie burn drinks, calorie burn flavor infusers, antioxidant shakes, antioxidant flavor infusers, bars, crunch bars, soups, chili, oatmeal, pudding, scrambled eggs, hot cocoa, cappuccino, chai latte, iced teas, fruit drinks, pretzels, puffs, brownie, pancakes, soy crisps, crackers, and omega 3 and digestive health products. Medifast Inc. sells its products through various channels of distribution comprising Web, call center, independent health advisors, medical professionals, weight loss clinics, and direct consumer marketing supported via the phone and the Web; Take Shape for Life, a physician led network of independent health coaches; and weight control centers. The company was founded in 1980 and is headquartered in Owings Mills, Maryland.


Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Medifast Inc  (NYSE:MED)Q4 2018 Earnings Conference CallFeb. 26, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    MediBloc [MED] (CURRENCY:MED) traded 11.7% lower against the U.S. dollar during the 1 day period ending at 20:00 PM ET on February 16th. MediBloc [MED] has a total market capitalization of $19.63 million and $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours. During the last seven days, MediBloc [MED] has traded down 27.6% against the U.S. dollar. One MediBloc [MED] token can currently be bought for $0.0066 or 0.00000100 BTC on major exchanges including Coinrail, Bibox and Gate.io.

  • [By Logan Wallace]

    State Board of Administration of Florida Retirement System raised its stake in Medifast Inc (NYSE:MED) by 12.4% during the second quarter, HoldingsChannel reports. The institutional investor owned 5,781 shares of the specialty retailer’s stock after buying an additional 640 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Medifast were worth $926,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    MediBloc [QRC20] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. It was first traded on January 3rd, 2014. MediBloc [QRC20]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. The official website for MediBloc [QRC20] is medibloc.org/en. MediBloc [QRC20]’s official Twitter account is @MEDDevTeam. The Reddit community for MediBloc [QRC20] is /r/MediBloc and the currency’s Github account can be viewed here. MediBloc [QRC20]’s official message board is medium.com/@MediBloc.

Hot Growth Stocks To Watch For 2023: Intuitive Surgical Inc.(ISRG)


Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems for various surgical procedures, including urologic, gynecologic, cardiothoracic, general, and head and neck surgeries. Its da Vinci surgical system consists of a surgeon?s console or consoles, a patient-side cart, a 3-D vision system, and proprietary ?wristed? instruments. The company?s da Vinci surgical system translates the surgeon?s natural hand movements on instrument controls at the console into corresponding micro-movements of instruments positioned inside the patient through small puncture incisions, or ports. It also manufactures a range of EndoWrist instruments, which incorporate wrist joints for natural dexterity for various surgical procedures. Its EndoWrist instruments consist of forceps, scissors, electrocautery, scalpels, and other surgical tools. In addition, it sells various vision and accessory products for use in conjunction with the da Vinci Surgical System as surgical procedures are performed. The company?s accessory products include sterile drapes used to ensure a sterile field during surgery; vision products, such as replacement 3-D stereo endoscopes, camera heads, light guides, and other items. It markets its products through sales representatives in the United States, and through sales representatives and distributors in international markets. The company was founded in 1995 and is headquartered in Sunnyvale, California.


Advisors’ Opinion:

  • [By Josh Enomoto]

    Finally, Gurufocus.com chimed in, noting EXEL is significantly undervalued. Financially, Exelixis features a robust balance sheet, solid three-year revenue growth rate and excellent net margins. Therefore, EXEL is one of the best undervalued biotech stocks to buy.

    Intuitive Surgical (ISRG) Source: Sundry Photography / Shutterstock.com

    Sometimes, we all need a little bit of a cheat sheet to get us through the finish line. For this list of undervalued biotech stocks to buy, I’m going to elect the services of Intuitive Surgical (NASDAQ:ISRG). To be clear, Intuitive Surgical doesn’t rate as many (if not most) people’s idea of a biotech firm. Rather than developing therapeutics, Intuitive specializes in robotic surgical systems.

  • [By Motley Fool Staff]

    For this episode, it’s time to check in on not one but two such samplers. First, it’s been one year since he offered up “Five Stocks I Own That You Should Too.” Those were Activision Blizzard (NASDAQ:ATVI), Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG), Intuitive Surgical (NASDAQ:ISRG), Match Group (NASDAQ:MTCH), and Zillow (NASDAQ:Z) (NASDAQ:ZG), and he’ll review their progress with senior analyst Jim Mueller.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Intuitive Surgical (ISRG)


    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Growth Stocks To Watch For 2023: Buffalo Wild Wings Inc.(BWLD)

Buffalo Wild Wings, Inc. engages in the ownership, operation, and franchise of restaurants in the United States. The company provides quick casual and casual dining services, as well as serves bottled beers, wines, and liquor. As of July 26, 2011, it had 773 Buffalo Wild Wings locations in 45 states in the United States, as well as in Canada. The company was founded in 1982 and is headquartered in Minneapolis, Minnesota.


Advisors’ Opinion:

  • [By Steve Symington]

    That’s not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen’s clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby’s Restaurant Group:

Hot Growth Stocks To Watch For 2023: TrueBlue Inc.(TBI)


TrueBlue, Inc. provides temporary blue-collar staffing services in the United States. It supplies on demand general labor to various industries under the Labor Ready brand; skilled labor to manufacturing and logistics industries under the Spartan Staffing brand; and trades people for commercial, industrial, and residential construction, and building and plant maintenance industries under the CLP Resources brand. The company also provides mechanics and technicians to the aviation maintenance, repair and overhaul, aerospace manufacturing, and assembly industries, as well as to other transportation industries under the Plane Techs brand; and temporary drivers to the transportation and distribution industries under the Centerline brand. It primarily serves small and medium-size businesses. The company was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. TrueBlue, Inc. was founded in 1985 and is headquartered in Tacoma, Washington.


Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine downgraded shares of Trueblue (NYSE:TBI) from a hold rating to a sell rating in a report issued on Friday morning.

    Several other research firms have also recently weighed in on TBI. Zacks Investment Research cut shares of Trueblue from a hold rating to a sell rating in a research report on Tuesday, February 12th. BMO Capital Markets decreased their price objective on shares of Trueblue from $26.00 to $24.00 and set a market perform rating for the company in a research report on Monday, February 11th. TheStreet cut shares of Trueblue from a b- rating to a c rating in a research report on Monday, December 31st. Finally, Credit Suisse Group decreased their price objective on shares of Trueblue from $31.00 to $25.00 and set a hold rating for the company in a research report on Tuesday, November 6th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. Trueblue presently has an average rating of Hold and a consensus price target of $26.00.

  • [By Motley Fool Transcribers]

    TrueBlue Inc  (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Trueblue Inc (NYSE:TBI) by 18.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,550 shares of the business services provider’s stock after purchasing an additional 4,700 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Trueblue were worth $823,000 as of its most recent filing with the Securities & Exchange Commission.

Leave a Reply

Your email address will not be published.